← All stocks

UNITED THERAPEUTICS Corp

UTHR Mostly scheduled
CIK 0001082554 #683 in the set updated 17 Sep 2026
Bought (12 mo)
$863.95K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.40B
$1.32M on a plan · $1.40B straight out of an exercise
Sold at will
$987.97K
3 of 2517 sales
Net
−$1.40B
−$124.02K against sales at will

By person

14 insiders · 2,518 transactions
122×

Martine Rothblatt holds 122 times base salary in stock. $188.72M of shares against $1.55M in salary for 2025.

Salary from the company's own proxy. The shares are what Martine Rothblatt last reported holding, valued at $504.57, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ROTHBLATT MARTINE A
Chairperson & CEO
$863.95K (1)
$826.92M (1717) scheduled
−$826.05M
374,024
0.8720%
$188.72M
+6.9%
BENKOWITZ MICHAEL
PRESIDENT AND COO
$236.34M (182) scheduled
−$236.34M
19,046
0.0444%
$9.61M
−83.8%
EDGEMOND JAMES
CFO AND TREASURER
$211.57M (384) scheduled
−$211.57M
18,876
0.0440%
$9.52M
+331.0%
MAHON PAUL A
EVP & GENERAL COUNSEL
$114.42M (199) scheduled
−$114.42M
45,172
0.1053%
$22.79M
+22.6%
SULLIVAN LOUIS W
Director
$3.05M (2) scheduled
−$3.05M
2,983
0.0070%
$1.51M
−79.8%
CAUSEY CHRISTOPHER
Director
$2.77M (6) scheduled
−$2.77M
4,190
0.0098%
$2.11M
+5.8%
PATUSKY CHRISTOPHER
Director
$2.73M (3) scheduled
−$2.73M
2,140
0.0050%
$1.08M
+137.8%
Thompson Tommy G
Director
$2.51M (5) scheduled
−$2.51M
8,480
0.0198%
$4.28M
0.0%
KURZWEIL RAY
Director
$2.40M (1) scheduled
−$2.40M
13,320
0.0311%
$6.72M
+10.3%
Olian Judy D.
Director
$1.16M (5)
−$1.16M
5,555
0.0130%
$2.80M
−25.0%
MALCOLM JAN
Director
$373.41K (9) scheduled
−$373.41K
450
0.0010%
$227.06K
Mesa Nilda
Director
$355.54K (4)
−$355.54K
5,580
0.0130%
$2.82M
−7.1%
Giltner Richard
Director
21,884
0.0510%
$11.04M
+25.6%
DWEK RAYMOND
Director
1,750
0.0041%
$883.00K
0.0%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 316
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 2,498
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 2,943,507
History held since 2 Sep 2016